Significance of the adrenal and sympathetic response to burn injury

Total Burn Care

Volumn , Issue , 2007, Pages 343-360

  Jones, Stephen B ^a   Muthu, Kuzhali ^b,c   Shankar, Ravi ^a   Gamelli, Richard L ^a,b,c,d  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Surgery ^*  (United States)

^c Burn and Shock Trauma Institute   (United States)

^d Burn Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78751591129     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3274-8.50028-3     Document Type: Chapter

References (276)

1. CR Benedict and DG Grahame-Smith (1978) Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med 47 1-20.
2. SA Murton, ST Tan, TC Prickett, et al. (1998) Hormone responses to stress in patients with major burns. Br J Plast Surg 51 388-392.
3. D Cuthbertson (1942) Post-shock metabolic response. Lancet 1 433-436.
4. H Selye (1936) A syndrome produced by diverse nocuous agents. Nature 138 32-33.
5. JJ Cunningham, MT Hegarty, PA Meara, et al. (1989) Measured and predicted calorie requirements of adults during recovery from severe burn trauma. Am J Clin Nutr 49 404-408.
6. R Khorram-Sefat, W Behrendt, A Heiden, et al. (1999) Long-term measurements of energy expenditure in severe burn injury. World J Surg 23 115-122.
7. HS Soroff, E Pearson and C Artz (1961) An estimation of nitrogen requirements for equilibrium in burned patients. Surg Gynecol Obstet 2 159.
8. EI Evans and WJH Butterfield (1951) The stress response in the severely burned. Ann Surg 134 588-613.
9. FD Moore (1949) Adaptation of supportive treatment to needs of the surgical patient. JAMA 141 646-653.
10. FHL Taylor, SM Levenson and MA Adams (1944) Abnormal carbohydrate metabolism in human thermal burns. N Engl J Med 231 437.
11. G Birke, H Duner, SO Liljedahl, et al. (1958) Histamine, catecholamines and adrenocortical steroids in burns. Acta Chir Scand 114 87-98.
12. M Goodall, C Stone and BW Haynes (1957) Urinary output of adrenaline and noradrenaline in severe thermal burns. Ann Surg 145 479-487.
13. RA Becker, GM Vaughan, CW Goodwin Jr, et al. (1980) Plasma norepinephrine, epinephrine, and thyroid hormone interactions in severely burned patients. Arch Surg 115 439-443.
14. G Birke, LA Carlson, US von Euler, et al. (1972) Studies on burns. XII. Lipid metabolism, catecholamine excretion, basal metabolic rate, and water loss during treatment of burns with warm dry air. Acta Chir Scand 138 321-333.
15. RL Crum, W Dominic, JF Hansbrough, et al. (1990) Cardiovascular and neurohumoral responses following burn injury. Arch Surg 125 1065-1069.
16. DW Wilmore and LH Aulick (1978) Metabolic changes in burned patients. Surg Clin North Am 58 1173-1187.
17. DW Wilmore, JM Long, AD Mason Jr, et al. (1974) Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg 180 653-669.
18. SC Carleton (1995) Cardiac problems associated with burns. Cardiol Clin 13 257-262.
19. D Michie, R Goldsmith and A Mason (1963) Hemodynamics of the immediate post-burn period. J Trauma 3 111-119.
20. BA Pruitt Jr (1971) Current treatment of thermal injury. South Med J 64 657-662.
21. K Ganrot, S Jacobsson and U Rothman (1974) Transcapillary passage of plasma proteins in experimental burns. Acta Physiol Scand 91 497-501.
22. HF Carvajal, JA Reinhart and DL Traber (1976) Renal and cardivascular functional response to thermal injury in dogs subjected to sympathetic blockade. Circ Shock 3 287-298.
23. WA Boyle and LD Segel (1986) Direct cardiac effects of vasopressin and their reversal by a vascular antagonist. Am J Physiol 251 H734-H741.
24. MJ Asch, RJ Feldman, HL Walker, et al. (1973) Systemic and pulmonary hemodynamic changes accompanying thermal injury. Ann Surg 178 218-221.
25. K Szabo (1989) Cardiac support in burned patients with heart disease. Acta Chir Plast 31 22-34.
26. J Bevan, B Pegram, J Prehn, et al. (1977) β-adrenergic receptor-mediated vasodilatation. P Vanhoutte, I Leusen (Eds) Mechanisms in vasodilatation New York: S Karger 258-265.
27. AJ Chruscinski, DK Rohrer, E Schauble, et al. (1999) Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem 274 16694-16700.
28. G Jacob, F Costa, J Shannon, et al. (2000) Dissociation between neural and vascular responses to sympathetic stimulation: contribution of local adrenergic receptor function. Hypertension 35 76-81.
29. J Sheperd (1983) Circulation to skeletal muscle. S Geiger, J Sheperd, F Abboud (Eds) Handbook of physiology section 2: the cardiovascular system: peripheral circulation and organ blood flow vol 3 Maryland: American Physiological Society 319-370.
30. RG Kilbourn, DL Traber and C Szabo (1997) Nitric oxide and shock. Dis Mon 43 277-348.
31. H Macarthur, TC Westfall, DP Riley, et al. (2000) Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 97 9753-9758.
32. H Macarthur, DM Couri, GH Wilken, et al. (2003) Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines. Crit Care Med 31 237-245.
33. LL Kolo, TC Westfall and H Macarthur (2004) Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed. Am J Physiol Heart Circ Physiol 286 H296-H303.
34. RR Wolfe and HI Miller (1976) Cardiovascular and metabolic responses during burn shock in the guinea pig. Am J Physiol 231 892-897.
35. RR Wolfe, HI Miller, D Elahi, et al. (1977) Effect of burn injury on glucose turnover in guinea pigs. Surg Gynecol Obstet 144 359-364.
36. G Arturson (1981) Metabolic changes and nutrition in children with severe burns. Prog Pediatr Surg 14 81-109.
37. E Breitenstein, RL Chiolero, E Jequier, et al. (1990) Effects of beta-blockade on energy metabolism following burns. Burns 16 259-264.
38. RR Wolfe and MJ Durkot (1982) Evaluation of the role of the sympathetic nervous system in the response of substrate kinetics and oxidation to burn injury. Circ Shock 9 395-406.
39. DN Herndon, TT Nguyen, RR Wolfe, et al. (1994) Lipolysis in burned patients is stimulated by the beta 2-receptor for catecholamines. Arch Surg 129 1301-1304. discussion 1304–1305.
40. RR Wolfe, DN Herndon, F Jahoor, et al. (1987) Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 317 403-408.
41. RR Wolfe, DN Herndon, EJ Peters, et al. (1987) Regulation of lipolysis in severely burned children. Ann Surg 206 214-221.
42. O Cope, G Nardi, M Ouijano, et al. (1953) Metabolic rate and thyroid function following acute thermal trauma in man. Ann Surg 137 165-174.
43. FT Caldwell Jr, H Ostermann, N Sower, et al. (1959) Metabolic response to thermal trauma of normal and thyroprivic rats at three environmental temperatures. Ann Surg 150 976-988.
44. FT Caldwell Jr (1976) Energy metabolism following thermal burns. Arch Surg 111 181-185.
45. WT Chance, JL Nelson, T Foley-Nelson, et al. (1989) The relationship of burn-induced hypermetabolism to central and peripheral catecholamines. J Trauma 29 306-312.
46. FT Caldwell Jr, DB Graves, BH Wallace, et al. (1989) Alteration in temperature regulation induced by burn injury in the rat. J Burn Care Rehabil 10 486-493.
47. WA Neely, AB Petro, GH Holloman Jr, et al. (1974) Researches on the cause of burn hypermetabolism. Ann Surg 179 291-294.
48. DN Herndon, RE Barrow, TC Rutan, et al. (1988) Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients. Ann Surg 208 484-492.
49. DN Herndon, DW Hart, SE Wolf, et al. (2001) Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 345 1223-1229.
50. KZ Shirani, BA Pruitt Jr and AD Mason Jr (1987) The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 205 82-87.
51. SB Jones, MF Kovarik and FD Romano (1986) Cardiac and splenic norepinephrine turnover during septic peritonitis. Am J Physiol 250 R892-R897.
52. SB Jones and FD Romano (1989) Dose- and time-dependent changes in plasma catecholamines in response to endotoxin in conscious rats. Circ Shock 28 59-68.
53. SB Jones, MV Westfall and MM Sayeed (1988) Plasma catecholamines during E. coli bacteremia in conscious rats. Am J Physiol 254 R470-R477.
54. MF Kovarik, SB Jones and FD Romano (1987) Plasma catecholamines following cecal ligation and puncture in the rat. Circ Shock 22 281-290.
55. ZZ Zhou and SB Jones (1993) Involvement of central vs. peripheral mechanisms in mediating sympathoadrenal activation in endotoxic rats. Am J Physiol 265 R683-R688.
56. ZZ Zhou, RD Wurster and SB Jones (1992) Arterial baroreflexes are not essential in mediating sympathoadrenal activation in conscious endotoxic rats. J Auton Nerv Syst 39 1-12.
57. W Calvo (1968) The innervation of the bone marrow in laboratory animals. J Anatomy 123 315-328.
58. SY Felten, DL Felten, DL Bellinger, et al. (1988) Noradrenergic sympathetic innervation of lymphoid organs. Prog Allergy 43 14-36.
59. FD Reilly, PA McCuskey, ML Miller, et al. (1979) Innervation of the periarteriolar lymphatic sheath of the spleen. Tissue Cell 11 121-126.
60. AJ Van Oosterhout and FP Nijkamp (1984) Anterior hypothalamic lesions prevent the endotoxin-induced reduction of beta-adrenoceptor number in guinea pig lung. Brain Res 302 277-280.
61. JM Williams and DL Felten (1981) Sympathetic innervation of murine thymus and spleen: a comparative histofluorescence study. Anat Rec 199 531-542.
62. KD Ackerman, SY Felten, DL Bellinger, et al. (1987) Noradrenergic sympathetic innervation of the spleen: III. Development of innervation in the rat spleen. J Neurosci Res 18 49-54.
63. DL Felten, KD Ackerman, SJ Wiegand, et al. (1987) Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J Neurosci Res 18 28-36.
64. DL Felten, SY Felten, SL Carlson, et al. (1985) Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135 755s-765s.
65. SY Felten and J Olschowka (1987) Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp. J Neurosci Res 18 37-48.
66. S Livnat, SY Felten, SL Carlson, et al. (1985) Involvement of peripheral and central catecholamine systems in neural-immune interactions. J Neuroimmunol 10 5-30.
67. Y Tang, R Shankar, R Gamelli, et al. (1999) Dynamic norepinephrine alterations in bone marrow: evidence of functional innervation. J Neuroimmunol 96 182-189.
68. AP Kohm and VM Sanders (1999) Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J Immunol 162 5299-5308.
69. DS Ramer-Quinn, RA Baker and VM Sanders (1997) Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol 159 4857-4867.
70. VM Sanders (1995) The role of adrenoceptor-mediated signals in the modulation of lymphocyte function. Adv Neuroimmunol 5 283-298.
71. VM Sanders, RA Baker, DS Ramer-Quinn, et al. (1997) Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 158 4200-4210.
72. MA Swanson, WT Lee and VM Sanders (2001) IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine. J Immunol 166 232-240.
73. DJ Kasprowicz, AP Kohm, MT Berton, et al. (2000) Stimulation of the B cell receptor, CD86 (B7–2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J Immunol 165 680-690.
74. KL Melmon, HR Bourne, Y Weinstein, et al. (1974) Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones. J Clin Invest 53 13-21.
75. AP Kohm, Y Tang, VM Sanders, et al. (2000) Activation of antigen-specific CD4+ Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow. J Immunol 165 725-733.
76. RN Spengler, SW Chensue, DA Giacherio, et al. (1994) Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J Immunol 152 3024-3031.
77. DW Beno and RE Kimura (1999) Nonstressed rat model of acute endotoxemia that unmasks the endotoxin-induced TNF-alpha response. Am J Physiol 276 H671-H678.
78. G Hasko, IJ Elenkov, V Kvetan, et al. (1995) Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumour necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J Endocrinol 144 457-462.
79. G Monastra and EF Secchi (1993) Beta-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release. Immunol Lett 38 127-130.
80. C Szabo, G Hasko, B Zingarelli, et al. (1997) Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 90 95-100.
81. J Szelenyi, JP Kiss and ES Vizi (2000) Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice. J Neuroimmunol 103 34-40.
82. T van der Poll, SM Coyle, K Barbosa, et al. (1996) Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97 713-719.
83. M Bergmann, A Gornikiewicz, T Sautner, et al. (1999) Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock 12 421-427.
84. X Guirao, A Kumar, J Katz, et al. (1997) Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation. Am J Physiol 273 E1203-E1208.
85. A Severn, NT Rapson, CA Hunter, et al. (1992) Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 148 3441-3445.
86. T van der Poll, J Jansen, E Endert, et al. (1994) Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 62 2046-2050.
87. T Yoshimura, C Kurita, T Nagao, et al. (1997) Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Pharmacology 54 144-152.
88. RC Chou, MW Stinson, BK Noble, et al. (1996) Beta-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-alpha production from rats with experimental arthritis. J Neuroimmunol 67 7-16.
89. XX Hu, EA Goldmuntz and CF Brosnan (1991) The effect of norepinephrine on endotoxin-mediated macrophage activation. J Neuroimmunol 31 35-42.
90. TA Ignatowski and RN Spengler (1995) Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. J Neuroimmunol 61 61-70.
91. J Liao, JA Keiser, WE Scales, et al. (1995) Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 268 R896-R901.
92. EY Bissonnette and AD Befus (1997) Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells. J Allergy Clin Immunol 100 825-831.
93. E Hetier, J Ayala, A Bousseau, et al. (1991) Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells. Exp Brain Res 86 407-413.
94. A Nakamura, EJ Johns, A Imaizumi, et al. (1998) Regulation of tumour necrosis factor and interleukin-6 gene transcription by beta2-adrenoceptor in the rat astrocytes. J Neuroimmunol 88 144-153.
95. VV Kalinichenko, MB Mokyr, LH Graf Jr, et al. (1999) Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. J Immunol 163 2492-2499.
96. C Abadie, S Foucart, P Page, et al. (1997) Interleukin-1 beta and tumor necrosis factor-alpha inhibit the release of [3H]-noradrenaline from isolated human atrial appendages. Naunyn Schmiedebergs Arch Pharmacol 355 384-389.
97. S Foucart and C Abadie (1996) Interleukin-1 beta and tumor necrosis factor-alpha inhibit the release of [3H]-noradrenaline from mice isolated atria. Naunyn Schmiedebergs Arch Pharmacol 354 1-6.
98. SM Hurst and SM Collins (1994) Mechanism underlying tumor necrosis factor-alpha suppression of norepinephrine release from rat myenteric plexus. Am J Physiol 266 G1123-G1129.
99. TA Ignatowski, BK Noble, JR Wright, et al. (1997) Neuronal-associated tumor necrosis factor (TNF alpha): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J Neuroimmunol 79 84-90.
100. RH DeRijk, A Boelen, FJ Tilders, et al. (1994) Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology 19 155-163.
101. A Takaki, QH Huang, A Somogyvari-Vigh, et al. (1994) Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1 335-342.
102. J van Gool, H van Vugt, M Helle, et al. (1990) The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol 57 200-210.
103. A Gornikiewicz, T Sautner, C Brostjan, et al. (2000) Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells. FASEB J 14 1093-1100.
104. B von Patay, H Loppnow, J Feindt, et al. (1998) Catecholamines and lipopolysaccharide synergistically induce the release of interleukin-6 from thymic epithelial cells. J Neuroimmunol 86 182-189.
105. D Maimone, C Cioni, S Rosa, et al. (1993) Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha. J Neuroimmunol 47 73-81.
106. JW Zumwalt, BJ Thunstrom and BL Spangelo (1999) Interleukin-1beta and catecholamines synergistically stimulate interleukin-6 release from rat C6 glioma cells in vitro: a potential role for lysophosphatidylcholine. Endocrinology 140 888-896.
107. L Burysek and J Houstek (1997) beta-Adrenergic stimulation of interleukin-1alpha and interleukin-6 expression in mouse brown adipocytes. FEBS Lett 411 83-86.
108. JD Christensen, EW Hansen, C Frederiksen, et al. (1999) Adrenaline influences the release of interleukin-6 from murine pituicytes: role of beta2-adrenoceptors. Eur J Pharmacol 378 143-148.
109. BD Jung, K Kimura, H Kitamura, et al. (2000) Norepinephrine stimulates interleukin-6 mRNA expression in primary cultured rat hepatocytes. J Biochem (Tokyo) 127 205-209.
110. JG Norris and EN Benveniste (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 45 137-145.
111. B von Patay, B Kurz and R Mentlein (1999) Effect of transmitters and co-transmitters of the sympathetic nervous system on interleukin-6 synthesis in thymic epithelial cells. Neuroimmunomodulation 6 45-50.
112. RH Straub, M Herrmann, G Berkmiller, et al. (1997) Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control. J Neurochem 68 1633-1639.
113. RH Straub, M Herrmann, T Frauenholz, et al. (1996) Neuroimmune control of interleukin-6 secretion in the murine spleen. Differential beta-adrenergic effects of electrically released endogenous norepinephrine under various endotoxin conditions. J Neuroimmunol 71 37-43.
114. RH Straub, HJ Linde, DN Mannel, J Scholmerich and W Falk (2000) A bacteria-induced switch of sympathetic effector mechanisms augments local inhibition of TNF-alpha and IL-6 secretion in the spleen. FASEB J 14 1380-1388.
115. C Platzer, W Docke, H Volk, et al. (2000) Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol 105 31-38.
116. B Siegmund, A Eigler, G Hartmann, et al. (1998) Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway. Int J Immunopharmacol 20 57-69.
117. C Woiciechowsky, K Asadullah, D Nestler, et al. (1998) Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 4 808-813.
118. G Hasko, ZH Nemeth, C Szabo, et al. (1998) Isoproterenol inhibits Il-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages. Brain Res Bull 45 183-187.
119. S Suberville, A Bellocq, B Fouqueray, et al. (1996) Regulation of interleukin-10 production by beta-adrenergic agonists. Eur J Immunol 26 2601-2605.
120. J Deng, K Muthu, R Gamelli, et al. (2004) Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis. Am J Physiol Cell Physiol 287 C730-C736.
121. K Muthu, J Deng, R Gamelli, et al. (2005) Adrenergic modulation of cytokine release in bone marrow progenitor-derived macrophage following polymicrobial sepsis. J Neuroimmunol 158 50-57.
122. M Lyte (1992) The role of catecholamines in gram-negative sepsis. Med Hypotheses 37 255-258.
123. M Lyte (1993) The role of microbial endocrinology in infectious disease. J Endocrinol 137 343-345.
124. M Lyte and MT Bailey (1997) Neuroendocrine-bacterial interactions in a neurotoxin-induced model of trauma. J Surg Res 70 195-201.
125. M Lyte and S Ernst (1993) Alpha and beta adrenergic receptor involvement in catecholamine-induced growth of gram-negative bacteria. Biochem Biophys Res Commun 190 447-452.
126. M Lyte, S Ernst, J Driemeyer, et al. (1991) Strain-specific enhancement of splenic T cell mitogenesis and macrophage phagocytosis following peripheral axotomy. J Neuroimmunol 31 1-8.
127. PP Freestone, RD Haigh, PH Williams, et al. (1999) Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiol Lett 172 53-60.
128. M Lyte, CD Frank and BT Green (1996) Production of an autoinducer of growth by norepinephrine cultured Escherichia coli O157:H7. FEMS Microbiol Lett 139 155-159.
129. M Lyte, BP Arulanandam and CD Frank (1996) Production of Shiga-like toxins by Escherichia coli O157:H7 can be influenced by the neuroendocrine hormone norepinephrine. J Lab Clin Med 128 392-398.
130. M Lyte, AK Erickson, BP Arulanandam, et al. (1997) Norepinephrine-induced expression of the K99 pilus adhesin of enterotoxigenic Escherichia coli. Biochem Biophys Res Commun 232 682-686.
131. L Iverson (1973) Neuronal and extraneuronal catecholamine uptake mechanisms. E Usdin, S Snyder (Eds) Frontiers in catecholamine research London: Pergamon 403-408.
132. RE Duque, SH Phan, JL Hudson, et al. (1985) Functional defects in phagocytic cells following thermal injury. Application of flow cytometric analysis. Am J Pathol 118 116-127.
133. KH Sartorelli, GM Silver and RL Gamelli (1991) The effect of granulocyte colony-stimulating factor (G-CSF) upon burn-induced defective neutrophil chemotaxis. J Trauma 31 523-529. discussion 529–530.
134. JS Solomkin (1990) Neutrophil disorders in burn injury: complement, cytokines, and organ injury. J Trauma 30 S80-S85.
135. GD Warden, AD Mason Jr and BA Pruitt Jr (1974) Evaluation of leukocyte chemotaxis in vitro in thermally injured patients. J Clin Invest 54 1001-1004.
136. V Peterson, J Hansbrough, C Buerk, et al. (1983) Regulation of granulopoiesis following severe thermal injury. J Trauma 23 19-24.
137. FJ Volenec, GW Wood, MM Mani, et al. (1979) Mononuclear cell analysis of peripheral blood from burn patients. J Trauma 19 86-93.
138. GJ Maestroni (1995) Adrenergic regulation of haematopoiesis. Pharmacol Res 32 249-253.
139. GJ Maestroni and A Conti (1994) Modulation of hematopoiesis via alpha 1-adrenergic receptors on bone marrow cells. Exp Hematol 22 313-320.
140. C Dresch, J Minc and JY Mary (1984) In vivo protection of normal mouse hematopoiesis by a beta 2 blocking agent during S-phase chemotherapy. Cancer Res 44 493-497.
141. C Dresch, J Minc, O Poirier, et al. (1981) Effect of beta adrenergic agonists and beta blocking agents on hemopoiesis in human bone marrow. Biomedicine 34 93-98.
142. GJ Maestroni, A Conti and E Pedrinis (1992) Effect of adrenergic agents on hematopoiesis after syngeneic bone marrow transplantation in mice. Blood 80 1178-1182.
143. M Togni and GJ Maestroni (1996) Hematopoietic rescue in mice via α1-adrenoceptors on bone marrow B cell precursors. Int J Oncol 313-318.
144. Y Tang, R Shankar, M Gamboa, et al. (2001) Norepinephrine modulates myelopoiesis after experimental thermal injury with sepsis. Ann Surg 233 266-275.
145. A Ayala and IH Chaudry (1996) Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 6 S27-S38.
146. E Faist (1996) The mechanisms of host defense dysfunction following shock and trauma. Curr Top Microbiol Immunol 216 259-274.
147. E Faist, C Schinkel, S Zimmer, et al. (1993) Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma 34 846-853. discussion 853–844.
148. CL Miller and CC Baker (1979) Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest 63 202-210.
149. CL Miller-Graziano, M Fink, JY Wu, et al. (1988) Mechanisms of altered monocyte prostaglandin E 2 production in severely injured patients. Arch Surg 123 293-299.
150. CL Miller-Graziano, G Szabo, K Kodys, et al. (1990) Aberrations in post-trauma monocyte (MO) subpopulation: role in septic shock syndrome. J Trauma 30 S86-S96.
151. CL Miller-Graziano, D Zhu and K Kodys (1994) Differential induction of human monocyte transforming growth factor beta 1 production and its regulation by interleukin 4. J Clin Immunol 14 61-72.
152. S Santangelo, RL Gamelli and R Shankar (2001) Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis. Ann Surg 233 97-106.
153. M Shoup, JM Weisenberger, JL Wang, et al. (1998) Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann Surg 228 112-122.
154. PJ Leenen, M Melis, WA Slieker and W Van Ewijk (1990) Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens. Eur J Immunol 20 27-34.
155. MF de Bruijn, WA Slieker, JC van der Loo, et al. (1994) Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur J Immunol 24 2279-2284.
156. MJ Cohen, R Shankar, J Stevenson, et al. (2004) Bone marrow norepinephrine mediates development of functionally different macrophages after thermal injury and sepsis. Ann Surg 240 132-141.
157. K Muthu, J Deng, F Romano, et al. (2005) Thermal injury and sepsis modulates beta-adrenergic receptors and cAMP responses in monocyte-committed bone marrow cells. J Neuroimmunol 165 129-138.
158. FD Moore (1957) Hormones and stress New York: Academic Press
159. DM Hume, DH Nelson and DW Miller (1956) Blood and urinary 17-hydroxycorticosteroids in patients with severe burns. Ann Surg 143 316-329.
160. FD Moore (1959) Metabolic care of the surgical patient Philadelphia: WB Saunders
161. JW Bane, RE McCaa, CS McCaa, et al. (1974) The pattern of aldosterone and cortisone blood levels in thermal burn patients. J Trauma 14 605-611.
162. L Wise, HW Margraf and WF Ballinger (1972) Adrenal cortical function in severe burns. Arch Surg 105 213-220.
163. RF Mortensen, AA Johnson and K Eurenius (1972) Serum corticosteroid binding following thermal injury. Proc Soc Exp Biol Med 139 877-882.
164. M Pugeat, A Bonneton, D Perrot, et al. (1989) Decreased immunoreactivity and binding activity of corticosteroid-binding globulin in serum in septic shock. Clin Chem 35 1675-1679.
165. DR Garrel (1996) Corticosteroid-binding globulin during inflammation and burn injury: nutritional modulation and clinical implications. Horm Res 45 245-251.
166. DR Garrel, L Zhang, XF Zhao, et al. (1993) Effect of burn injury on corticosteroid-binding globulin levels in plasma and wound fluid. Wound Rep Reg 1 10-14.
167. D Feldman, CE Mondon, JA Horner, et al. (1979) Glucocorticoid and estrogen regulation of corticosteroid-binding globulin production by rat liver. Am J Physiol 237 E493-E499.
168. R Frairia, F Agrimonti, N Fortunati, et al. (1988) Influence of naturally occurring and synthetic glucocorticoids on corticosteroid-binding globulin-steroid interaction in human peripheral plasma. Ann N Y Acad Sci 538 287-303.
169. CL Smith and GL Hammond (1992) Hormonal regulation of corticosteroid-binding globulin biosynthesis in the male rat. Endocrinology 130 2245-2251.
170. A Emptoz-Bonneton, JC Crave, H LeJeune, et al. (1997) Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells. J Clin Endocrinol Metab 82 3758-3762.
171. I Vermes, A Beishuizen, RM Hampsink, et al. (1995) Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hor-mone. J Clin Endocrinol Metab 80 1238-1242.
172. M Kellner, K Wiedemann and F Holsboer (1992) Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 50 1835-1842.
173. JP Hinson, GP Vinson, S Kapas, et al. (1991) The role of endothelin in the control of adrenocortical function: stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin-3 on steroidogenesis in rat and human adrenocortical cells. J Endocrinol 128 275-280.
174. M Hirai, S Miyabo, E Ooya, et al. (1991) Endothelin-3 stimulates the hypothalamic–pituitary–adrenal axis. Life Sci 48 2359-2363.
175. H Vierhapper, U Hollenstein, M Roden, et al. (1993) Effect of endothelin-1 in man – impact on basal and stimulated concentrations of luteinizing hormone, follicle-stimulating hormone, thyrotropin, growth hormone, corticotropin, and prolactin. Metabolism 42 902-906.
176. CR Parker Jr and CR Baxter (1985) Divergence in adrenal steroid secretory pattern after thermal injury in adult patients. J Trauma 25 508-510.
177. ED Lephart, CR Baxter and CR Parker Jr (1987) Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab 64 842-848.
178. P Doerr and KM Pirke (1976) Cortisol-induced suppression of plasma testosterone in normal adult males. J Clin Endocrinol Metab 43 622-629.
179. TH Welsh Jr, TH Bambino and AJ Hsueh (1982) Mechanism of glucocorticoid-induced suppression of testicular androgen biosynthesis in vitro. Biol Reprod 27 1138-1146.
180. BH Wallace, FT Caldwell Jr and JB Cone (1994) The interrelationships between wound management, thermal stress, energy metabolism, and temperature profiles of patients with burns. J Burn Care Rehabil 15 499-508.
181. SP Allison, P Hinton and MJ Chamberlain (1968) Intravenous glucose-tolerance, insulin, and free-fatty-acid levels in burned patients. Lancet 2 1113-1116.
182. JE Plager and N Matsui (1966) An in vitro demonstration of the anti-insulin action of cortisol on glucose metabolism. Endocrinology 78 1154-1158.
183. RR Wolfe, MJ Durkot, JR Allsop, et al. (1979) Glucose metabolism in severely burned patients. Metabolism 28 1031-1039.
184. RR Wolfe, HI Miller and JJ Spitzer (1977) Glucose and lactate kinetics in burn shock. Am J Physiol 232 E415-E418.
185. DM Yarmush, AD MacDonald, BD Foy, et al. (1999) Cutaneous burn injury alters relative tricarboxylic acid cycle fluxes in rat liver. J Burn Care Rehabil 20 292-302.
186. JM Shuck, P Eaton, LW Shuck, et al. (1977) Dynamics of insulin and glucagon secretions in severely burned patients. J Trauma 17 706-713.
187. GM Vaughan, RA Becker, RH Unger, et al. (1985) Nonthyroidal control of metabolism after burn injury: possible role of glucagon. Metabolism 34 637-641.
188. J Marco, C Calle, D Roman, et al. (1973) Hyperglucagonism induced by glucocorticoid treatment in man. N Engl J Med 288 128-131.
189. DP Cuthbertson (1932) Observations on disturbance of metabolism produced by injury to the limbs. QJM 25 233-246.
190. D Darmaun, DE Matthews and DM Bier (1988) Physiological hypercortisolemia increases proteolysis, glutamine, and alanine production. Am J Physiol 255 E366-E373.
191. AG Kayali, VR Young and MN Goodman (1987) Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis. Am J Physiol 252 E621-E626.
192. CH Fang, HJ James, C Ogle, et al. (1995) Influence of burn injury on protein metabolism in different types of skeletal muscle and the role of glucocorticoids. J Am Coll Surg 180 33-42.
193. RC May, RA Kelly and WE Mitch (1986) Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 77 614-621.
194. SR Price, BK England, JL Bailey, et al. (1994) Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol 267 C955-C960.
195. U Isozaki, WE Mitch, BK England, et al. (1996) Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H1 myocytes require an interaction between glucocorticoids and acidification. Proc Natl Acad Sci USA 93 1967-1971.
196. X Ding, SR Price, JL Bailey, et al. (1997) Cellular mechanisms controlling protein degradation in catabolic states. Miner Electrolyte Metab 23 194-197.
197. JL Bailey, X Wang, BK England, et al. (1996) The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97 1447-1453.
198. R Medina, SS Wing and AL Goldberg (1995) Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 307 631-637.
199. WE Mitch, R Medina, S Grieber, et al. (1994) Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 93 2127-2133.
200. SR Price, JL Bailey, X Wang, et al. (1996) Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 98 1703-1708.
201. SS Wing and AL Goldberg (1993) Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 264 E668-E676.
202. LH Aulick and DW Wilmore (1979) Increased peripheral amino acid release following burn injury. Surgery 85 560-565.
203. SF Abcouwer, R Lohmann, BP Bode, et al. (1997) Induction of glutamine synthetase expression after major burn injury is tissue specific and temporally variable. J Trauma 42 421-427. discussion 427–428.
204. SF Abcouwer, BP Bode and WW Souba (1995) Glucocorticoids regulate rat glutamine synthetase expression in a tissue-specific manner. J Surg Res 59 59-65.
205. DW Hart, SE Wolf, R Mlcak, et al. (2000) Persistence of muscle catabolism after severe burn. Surgery 128 312-319.
206. EA Milner, WG Cioffi, AD Mason, et al. (1994) A longitudinal study of resting energy expenditure in thermally injured patients. J Trauma 37 167-170.
207. FF Casanueva (1992) Physiology of growth hormone secretion and action. Endocrinol Metab Clin North Am 21 483-517.
208. CJ Rosen and M Pollak (1999) Circulating IGF-1: new perspectives for a new century. Trends Endocrinol Metab 10 136-141.
209. T Abribat, P Brazeau, I Davignon, et al. (1993) Insulin-like growth factor-I blood levels in severely burned patients: effects of time post injury, age of patient and severity of burn. Clin Endocrinol (Oxf) 39 583-589.
210. A Bereket, TA Wilson, SL Blethen, et al. (1996) Regulation of the acid-labile subunit of the insulin-like growth factor ternary complex in patients with insulin-dependent diabetes mellitus and severe burns. Clin Endocrinol (Oxf) 44 525-532.
211. SC Davies, JA Wass, RJ Ross, et al. (1991) The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 130 469-473.
212. A Ghahary, S Fu, YJ Shen, et al. (1994) Differential effects of thermal injury on circulating insulin-like growth factor binding proteins in burn patients. Mol Cell Biochem 135 171-180.
213. S Moller, M Jensen, P Svensson, et al. (1991) Insulin-like growth factor 1 (IGF-1) in burn patients. Burns 17 279-281.
214. J Dai and RC Baxter (1994) Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex. Endocrinology 135 2335-2341.
215. J Dai, CD Scott and RC Baxter (1994) Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes. Endocrinology 135 1066-1072.
216. GA Al Shamma, CC Goll, TB Baird, et al. (1979) Changes in body composition after thermal injury in the rat. Br J Nutr 42 267-275.
217. SN Fain, RO Scow and SS Chernick (1963) Effects of glucocorticoids on-metabolism of adipose tissue in vitro. J Biol Chem 238 54-58.
218. AD Galster, DM Bier, PE Cryer, et al. (1984) Plasma palmitate turnover in subjects with thermal injury. J Trauma 24 938-945.
219. RL Harris, RA Frenkel, GL Cottam, et al. (1982) Lipid mobilization and metabolism after thermal trauma. J Trauma 22 194-198.
220. GL Klein, DN Herndon, TC Rutan, et al. (1993) Bone disease in burn patients. J Bone Miner Res 8 337-345.
221. MB Schaffler, XJ Li, WS Jee, et al. (1988) Skeletal tissue responses to thermal injury: an experimental study. Bone 9 397-406.
222. GL Klein, DN Herndon, CB Langman, et al. (1995) Long-term reduction in bone mass after severe burn injury in children. J Pediatr 126 252-256.
223. RL Rutan and DN Herndon (1990) Growth delay in postburn pediatric patients. Arch Surg 125 392-395.
224. GL Klein, SE Wolf, WG Goodman, et al. (1997) The management of acute bone loss in severe catabolism due to burn injury. Horm Res 48 83-87.
225. RS Weinstein, RL Jilka, AM Parfitt, et al. (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102 274-282.
226. E Canalis (1996) Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81 3441-3447.
227. E Canalis, S Rydziel, AM Delany, et al. (1995) Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 136 1348-1354.
228. DW Dempster, BS Moonga, LS Stein, et al. (1997) Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. J Endocrinol 154 397-406.
229. I Manelli and I Giustina (2000) Glucocorticoid-induced osteoporosis. Trends Endocrinol Metab 11 79-85.
230. C Jux, K Leiber, U Hugel, et al. (1998) Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 139 3296-3305.
231. DN Herndon and ST Zeigler (1993) Bacterial translocation after thermal injury. Crit Care Med 21 S50-S54.
232. M Colic, S Mitrovic and A Dujic (1989) Thymic response to thermal injury in mice: I. Alterations of thymocyte subsets studied by flow cytometry and immunohistochemistry. Burns 15 155-161.
233. T Nakanishi, Y Nishi, EF Sato, et al. (1998) Thermal injury induces thymocyte apoptosis in the rat. J Trauma 44 143-148.
234. MD Maldonado, A Venturoli, A Franco, et al. (1991) Specific changes in peripheral blood lymphocyte phenotype from burn patients. Probable origin of the thermal injury-related lymphocytopenia. Burns 17 188-192.
235. BC Organ, AC Antonacci, J Chiao, et al. (1989) Changes in lymphocyte number and phenotype in seven lymphoid compartments after thermal injury. Ann Surg 210 78-89.
236. H Selye (1936) Thymus and adrenals in the response of organism to injuries and intoxications. Br J Exp Pathol 17.
237. H Blomgren and B Andersson (1970) Characteristics of the immunocompetent cells in the mouse thymus: cell population changes during cortisone-induced atrophy and subsequent regeneration. Cell Immunol 1 545-560.
238. WK Cowan and DG Sorenson (1964) Electron microscopic observations of acute thymic involution produced by hydrocortisone. Lab Invest 13 353-370.
239. S Gillis, GR Crabtree and KA Smith (1979) Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 123 1624-1631.
240. T Taniguchi (1988) Regulation of cytokine gene expression. Annu Rev Immunol 6 439-464.
241. MV Tolentino, MM Sarasua, OA Hill, et al. (1991) Peripheral lymphocyte membrane fluidity after thermal injury. J Burn Care Rehabil 12 498-504.
242. DC Dale, AS Fauci and SM Wolff (1974) Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. N Engl J Med 291 1154-1158.
243. JJ Rinehart, SP Balcerzak, AL Sagone, et al. (1974) Effects of corticosteroids on human monocyte function. J Clin Invest 54 1337-1343.
244. PA Ward (1966) The chemosuppression of chemotaxis. J Exp Med 124 209-226.
245. RR MacGregor, PJ Spagnuolo and AL Lentnek (1974) Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system. N Engl J Med 291 642-646.
246. GL Mandell, W Rubin and EW Hook (1970) The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity. J Clin Invest 49 1381-1388.
247. JB Hibbs Jr (1974) Heterocytolysis by macrophages activated by bacillus Calmette-Guerin: lysosome exocytosis into tumor cells. Science 184 468-471.
248. G Arturson, CF Hogman, SG Johansson, et al. (1969) Changes in immunoglobulin levels in severely burned patients. Lancet 1 546-548.
249. AB Bjornson, WA Altemeier and HS Bjornson (1977) Changes in humoral components of host defense following burn trauma. Ann Surg 186 88-96.
250. RJ Kagan, A Bratescu, O Jonasson, et al. (1989) The relationship between the percentage of circulating B cells, corticosteroid levels, and other immunologic parameters in thermally injured patients. J Trauma 29 208-213.
251. M Kawakami, AA Meyer, S deSerres, et al. (1990) Effects of acute ethanol ingestion and burn injury on serum immunoglobulin. J Burn Care Rehabil 11 395-399.
252. J Kohn and DF Cort (1969) Immunoglobulins in burned patients. Lancet 1 836-837.
253. AM Munster, HC Hoagland and BA Pruitt Jr (1970) The effect of thermal injury on serum immunoglobulins. Ann Surg 172 965-969.
254. M Kawakami, S deSerres and AA Meyer (1991) Immunoglobulin synthesis by cultured lymphocytes from spleen and mesenteric lymph nodes after thermal injury. J Burn Care Rehabil 12 474-481.
255. H Sakai, JC Daniels, GA Beathard, et al. (1974) Mixed lymphocyte culture reaction in patients with acute thermal burns. J Trauma 14 53-57.
256. WT Butler and RD Rossen (1973) Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest 52 2629-2640.
257. BA Araneo, J Shelby, GZ Li, et al. (1993) Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch Surg 128 318-325.
258. KL Blauer, M Poth, WM Rogers, et al. (1991) Dehydroepian-drosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129 3174-3179.
259. RA Daynes, AW Meikle and BA Araneo (1991) Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res Immunol 142 40-45.
260. T Suzuki, N Suzuki, RA Daynes, et al. (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 61 202-211.
261. SS Devins, A Miller, BL Herndon, et al. (1992) Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 20 1644-1649.
262. G Van den Berghe, F de Zegher, P Wouters, et al. (1995) Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin Endocrinol (Oxf) 43 457-463.
263. K Higuchi, H Nawata, T Maki, et al. (1984) Prolactin has a direct effect on adrenal androgen secretion. J Clin Endocrinol Metab 59 714-718.
264. GR Van Loon, L Schwartz and MJ Sole (1979) Plasma dopamine responses to standing and exercise in man. Life Sci 24 2273-2277.
265. CE Viquerat, P Daly, K Swedberg, et al. (1985) Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities. Am J Med 78 455-460.
266. XM Wang, L Yang and KM Chen (1993) Catecholamines: important factors in the increase of oxidative phosphorylation coupling in rat-liver mitochondria during the early phase of burn injury. Burns 19 110-112.
267. MJ Durkot and RR Wolfe (1981) Effects of adrenergic blockade on glucose kinetics in septic and burned guinea pigs. Am J Physiol 241 R222-R227.
268. DW Wilmore, LH Aulick, AD Mason, et al. (1977) Influence of the burn wound on local and systemic responses to injury. Ann Surg 186 444-458.
269. PQ Bessey, JM Watters, TT Aoki, et al. (1984) Combined hormonal infusion simulates the metabolic response to injury. Ann Surg 200 264-281.
270. GF Batstone, PL Levick, E Spurr, et al. (1983) Changes in acute phase reactants and disturbances in metabolism after burn injury. Burns Incl Therm Inj 9 234-239.
271. GF Batstone, KGMM Alberti, L Hinks, et al. (1976) Metabolic studies in subects following thermal injury. Burns 2 207-225.
272. L Sevaljevic, M Petrovic, D Bogojevic, et al. (1989) Acute-phase response to scalding: changes in serum properties and acute-phase protein concentrations. Circ Shock 28 293-307.
273. SE Calvano, JD Albert, A Legaspi, et al. (1987) Comparison of numerical and phenotypic leukocyte changes during constant hydrocortisone infusion in normal humans with those in thermally injured patients. Surg Gynecol Obstet 164 509-520.
274. ML Webel, RE Ritts Jr, HF Taswell, et al. (1974) Cellular immunity after intravenous administration of methylprednisolone. J Lab Clin Med 83 383-392.
275. S Wallner, R Vautrin, J Murphy, et al. (1984) The haematopoietic response to burning: studies in an animal model. Burns Incl Therm Inj 10 236-251.
276. JJ Rinehart, AL Sagone, SP Balcerzak, et al. (1975) Effects of corticosteroid therapy on human monocyte function. N Engl J Med 292 236-241.